Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
How miRNAs Tune Juvenile Hormone in Locusts
2026-11-18
A 2025 migratory locust study connected stage-specific juvenile hormone production with coordinated miRNA control of biosynthetic genes, vitellogenin expression, and ovarian development. Its methoprene perturbation supported a downstream hormonal role in reproduction, while the strongest mechanistic evidence came from the miRNA–mRNA network in the corpora allata.
How DTP3 Redirects GADD45β/MKK7 Signaling
2026-11-18
DTP3 is described as an inhibitor of the GADD45β/MKK7 complex that may connect NF-κB-associated survival signaling with JNK-linked apoptosis. The documented evidence spans molecular binding, tumor-cell selectivity, signaling readouts, and myeloma xenograft growth, with each level supporting a different research interpretation rather than establishing clinical efficacy.
How SCD1 Inhibition Selects Against hPSCs
2026-11-17
PluriSIn 1 (NSC 14613) is documented as a pluripotent cell-selective compound whose reported activity involves blocking SCD1-dependent oleate synthesis. The resulting lipid imbalance is linked to endoplasmic-reticulum stress, reduced protein synthesis, and apoptosis, but the evidence supports a mechanistic interpretation rather than a complete demonstration of clinical or product-specific performance.
Phosphorylated H1 Organizes Repair at Stressed Forks
2026-11-17
A mechanistic study links S-phase phosphorylation of linker histone H1 to stronger association with replication-fork ssDNA, recruitment of HPF1 and related repair factors, and cellular genome-protection phenotypes. The evidence converges across biochemical, imaging, cellular-rescue and lymphoma-dataset analyses, while phosphomimic models and qualitative assembly assays limit how directly the mechanism can be generalized.
CCR7–Notch1 Crosstalk: What the Evidence Shows
2026-11-16
A defined murine mammary-tumor study links CCR7 stimulation to Notch1 cleavage, downstream Hes1 activity and stem-like behavior. The evidence supports functional pathway crosstalk within the MMTV-PyMT model, while leaving human relevance, tumor-level causality and therapeutic value unresolved.
What Does a Doripenem Readout Measure?
2026-11-16
Doripenem-associated growth or viability signals are downstream consequences of altered bacterial cell-wall assembly, not direct measurements of penicillin-binding-protein engagement. This article separates molecular target interaction, envelope damage, population change and assay interpretation while defining what the product documentation supports—and what remains uncertain.
What Does Anti-ALCAM/CD166 Binding Show?
2026-11-15
Binding by Praluzatamab can support detection of ALCAM/CD166 and interpretation of antigen-associated assay signals, but it does not by itself establish receptor function, disease causality, therapeutic benefit, or an animal-model outcome.
How Ceftiofur Sodium Shapes Bacterial Readouts
2026-11-14
Ceftiofur sodium assay signals are best interpreted as a chain from cephalosporin chemistry to cell-wall disruption and then to population-level change. Product documentation supports identity, physicochemical characterization, and a class-level mechanism, while organism-specific activity and assay performance remain biological questions.
How D-AP5 Links NMDA Blockade to Neural Readouts
2026-11-13
D-AP5 is described as a competitive NMDA receptor antagonist that connects receptor-level blockade with changes in synaptic currents, calcium signaling, plasticity, and excitotoxic neuronal survival. Interpreting these findings requires distinguishing direct electrical effects from downstream cellular outcomes and keeping model-based neuroprotection claims separate from clinical efficacy.
U1 Promoters and Cytosolic Cas13 Guide Activity
2026-11-13
A comparative cell-based study found that U1-driven CRISPR RNAs were more cytosol-enriched than U6-driven guides and showed stronger activity across Cas13 knockdown, RNA editing, translational repression, and reporter-regulation assays. The findings link guide localization with transcript-end processing, while also showing that the effect depends on the Cas13 partner and guide architecture.
How O-GlcNAcylation Couples Wnt to Bone Formation
2026-11-12
A mechanistic preclinical study links Wnt-driven osteogenesis to O-GlcNAcylation-dependent aerobic glycolysis and identifies PDK1 modification as a possible metabolic relay. Cell and mouse findings support a context-dependent model in which O-GlcNAcylation is especially important for some bone-forming responses, while other Wnt effects remain partly independent of it.
Dual-Targeting CAR-T in Heterogeneous NSCLC
2026-11-12
A paper-centred interpretation of a preclinical study examining whether dual recognition of CD276 and NKG2D ligands can improve CAR-T engagement, functional persistence, and tumor control across heterogeneous non-small cell lung cancer models.
How CD20 Targeting Connects to Lesion Inhibition
2026-11-11
Ocrelizumab is described as a humanized anti-CD20 antibody that depletes B cells through antibody-dependent cellular cytotoxicity and inhibits multiple-sclerosis lesions in mice. The key interpretive question is how a molecular targeting event becomes a cellular and tissue-level readout, and what the mouse finding can—and cannot—establish.
Conserved Claustrum Subdivisions Across Mammals
2026-11-11
A comparative neuroanatomical study examines whether claustrum-complex subdivisions remain recognizable across mammals despite major differences in brain size and morphology. The evidence supports conserved molecular and topological organization, while indicating that primate and large-brained mammal comparisons remain incomplete.
How Tricine Shapes Biochemical pH Readouts
2026-11-10
Tricine is best interpreted as a chemical buffer component that moderates proton-driven changes in a biochemical system. Its documented identity and role support mechanistic interpretation, but they do not by themselves establish how any particular assay will perform.